A reliable identification of cerebral metabolites is fundamental to applications of in vivo nuclear magnetic resonance (NMR) spectroscopy to neurochemical research and clinical diagnosis. Although extensive knowledge has been compiled in the literature, complications still arise from (i) species differences including man; (ii) alterations of in vivo metabolic profiles by tissue selection and in vitro preparation; and (iii) the use of variable NMR field strengths, signal types, and relaxation effects. Taking these aspects into account, we previously assigned the singlet resonance at 3.35 pprn in proton NMR spectra of human gray matter to scyllo-inositol (scyllo-Ins) both under in vitro conditions and in vivo (1). Moreover, the concentration of scyllo-Ins was found to be correlated with that of myo-inositol (myo-Ins). These observations were confirmed in high-resolution proton NMR studies of hepatic encephalopathy (z), multiple sclerosis (3), and breast carcinomas (4).
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More recently, however, the scyllo-Ins assignment was questioned by Preece et al. in a paper entitled "Experimental encephalomyelitis modulates inositol and taurine in the spinal cord of Biozzi mice" (5). The authors noticed that the 3.35 pprn resonance in their proton NMR spectra of perchloric acid (PCA) extracts of brain tissue did not correlate with alterations of myo-Ins in experimental allergic encephalomyelitis. They concluded that the observed resonance was due to a preparation artifact resulting from methanol in the swabbing solution. Although the additional presence of scyllo-Ins could not be ruled out, a methanol contamination was proven by investigations of the used swabbing solution.
The purpose of this Letter is to confirm our previous identification of scyllo-Ins in human, bovine, and sheep gray matter. Figure 1 shows two high-resolution 7.0 T proton NMR spectra of PCA extracts of bovine medulla in the 3.0-4.0 pprn chemical shift range. Spiking with methanol clearly reveals two separate singlet resonances shifted by 1.2 Hz and thus allows an unambiguous distinction of methanol (at 3.354 ppm) and scyllo-hs (at 3.350 ppm).
In general, Preece et al. correctly point out that methanol may give rise to an artifactual signal contribution that may be mistaken for scyllo-Ins in proton NMR spectra of brain tissue. Control experiments should involve resonance "spiking" with either scyllo-Ins or methanol and extended to chemicals and solutions used for extract preparation. In addition, investigators should be aware of 
RESPONSE
We welcome the additional data regarding the unambiguous observation of scyllo-inositol (scyllo-Ins) in the brains of larger mammals now provided by Michaelis and Frahm, not least because their figure (after methanol "spiking") graphically demonstrates the potential for error inherent in the NMR assignation of singlets in extract and biofluid studies, let alone those studies performed in vivo. We remind your readers that in our paper, we did not question the specific findings of Michaelis et al. We simply pointed out that in our own study of Biozzi mouse spinal cord the prominent singlet seen at 3.35 ppm could be attributed to methanol contamination, although we could not rule out the additional presence of scyllo-Ins. The closeness of the two resonance frequencies serves to emphasize the care that needs to be taken when assigning singlet peaks such as these, and we agree completely with Michaelis and Frahm about the importance of "spiking." Regarding the diminished or absent scyllo-Ins signal seen in rodent brain, we have had limited success in detecting scyllo-Ins in rat, mouse and guinea-pig brain, despite the original retrospective analysis of literature data reported by Michaelis et al., which claimed to reveal the presence of scyllo-Ins in three earlier key studies of rat brain (see (1) for refs).
In general with an insensitive technique such as NMR spectroscopy, intense singlets (particularly those from co-resonant protons) become most attractive for detection, because the strong signal is not split by J-coupling. Unfortunately when a well resolved singlet is the only prominent signal from the metabolite, as is the case with scyllo-Ins (and certain N-trimethyl compounds), the absence of coupling effects, either in 1- 
